Michael F. Bigham

Michael has 14 years of operational experience and six years investment banking experience in life science companies and has been with Abingworth since 2002. He was formerly Vice Chairman of Corixa and was President and Chief Executive of Coulter Pharmaceuticals from 1996 until it merged into Corixa in 2000. Previously, he was an early employee at Gilead Sciences, where he spent eight years serving in various capacities, including Executive Vice President of Operations and CFO. Before joining Gilead, Michael was a partner at Hambrecht & Quist, where he became Co-Head of Healthcare Investment Banking. His directorships have included Avila Therapeutics, Magellan, Primera Biosystems, Supernus Pharmaceuticals and Valeritas. Michael has a BS Degree in Commerce from the University of Virginia and qualified as a CPA before completing his MBA at Stanford University. He is responsible for Abingworth’s Boston office and focuses on growth equity and East Coast venture deal

Michael F. Bigham is the Executive Partner at Abingworth, based in United States, North America. With a background in Biotechnology, Michael F. Bigham has a rich history of leadership and innovation. Michael F. Bigham studied B.Com Accounting and Finance @ University of Virginia. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.